9/11/2025HKU-Med, GBAICTI and GSK Join Forces to Boost Real-World Clinical Rese...

9/11/2025Chinese Biotechs Face Rising Hurdles in Advanced Therapies

9/10/2025Trump Admin Weighs Tighter Curbs on U.S. Licensing of China-Originated...

9/10/2025YolTech Secures $45M to Accelerate CRISPR Therapy Development Amid U.S...

9/9/2025China's NMPA Seeks Public Feedback on Draft Guidelines for Online Pres...

9/9/2025China's PD-(L)1 Market Shows Continued Growth in H1 2025, Domestic Bra...

9/9/2025RemeGen's Telitacicept Advances in Sjögren's Syndrome

9/9/2025BioNTech and BMS Report Promising Global Phase II Data for Pumitamig

9/8/2025NHSA Seeks Feedback on Draft Implementation Rules for Medical Insuranc...

9/8/2025CDE Opens Public Consultation on Draft Guidelines for Clinical Trials ...

9/8/2025CDE Invites Feedback on Draft Guidelines for Clinical Trials of Target...

9/8/2025CDE Seeks Comments on Draft Guidelines for Clinical Trials of Anti-Fib...

9/8/2025CDE Solicits Comments on Draft Guidelines for Type I Meetings on Advan...

9/8/2025CDE Opens Public Consultation on Draft Guidelines for Type I Meetings ...

9/8/2025CDE Seeks Comments on Draft Technical Guidelines for Chemically Synthe...

9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...

9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...

9/8/2025CDE Issues Technical Guidelines for Clinical Pharmacology Research on ...

9/8/2025NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...

9/8/2025Junshi Achieves Positive Phase 3 Results for JS005 in Psoriasis Treatm...

9/8/2025Innovent's Tigulixostat Demonstrates Superior Efficacy in Phase 2 Gout...

9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...

9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...

9/8/2025Avadel Partners with XWPharma to Advance Valiloxybate for Sleep Disord...

9/8/2025Epigenic Secures $60M in Series B Financing to Advance Epigenetic Drug...

9/5/2025Hengrui Licenses Myosin Inhibitor HRS-1893 to U.S. Startup Braveheart ...

9/5/2025Yangtze River's Fexuprazan Gains Chinese Approval

9/5/20253SBio Secures IND Nod for Dual-Target CAR-T Therapy SA102

9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...

9/4/2025CDE Seeks Comments on Draft Guidelines for Pan-Cancer Drug Development

Page:16/58 Total number of articles:1731: [First][<<] [14] [15] [16] [17] [18] [>>] [End]